$228.12
0.52% yesterday
NYSE, Dec 26, 10:10 pm CET
ISIN
US0758871091
Symbol
BDX

Becton, Dickinson & Stock price

$228.12
+3.87 1.73% 1M
-3.50 1.51% 6M
-15.71 6.44% YTD
-15.18 6.24% 1Y
-16.90 6.90% 3Y
-36.15 13.68% 5Y
+92.27 67.92% 10Y
NYSE, Closing price Thu, Dec 26 2024
+1.17 0.52%
ISIN
US0758871091
Symbol
BDX
Sector

Key metrics

Market capitalization $65.82b
Enterprise Value $84.44b
P/E (TTM) P/E ratio 38.20
EV/FCF (TTM) EV/FCF 27.48
EV/Sales (TTM) EV/Sales 4.18
P/S ratio (TTM) P/S ratio 3.26
P/B ratio (TTM) P/B ratio 2.53
Dividend yield 1.67%
Last dividend (FY24) $3.80
Revenue growth (TTM) Revenue growth 4.16%
Revenue (TTM) Revenue $20.18b
EBIT (operating result TTM) EBIT $2.88b
Free Cash Flow (TTM) Free Cash Flow $3.07b
Cash position $2.30b
EPS (TTM) EPS $5.94
P/E forward 25.81
P/S forward 2.99
EV/Sales forward 3.84
Short interest 0.73%
Show more

Is Becton, Dickinson & a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,885 stocks worldwide.

Becton, Dickinson & Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Becton, Dickinson & forecast:

16x Buy
89%
2x Hold
11%

Analyst Opinions

18 Analysts have issued a Becton, Dickinson & forecast:

Buy
89%
Hold
11%

Financial data from Becton, Dickinson &

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
20,178 20,178
4% 4%
100%
- Direct Costs 11,025 11,025
2% 2%
55%
9,153 9,153
12% 12%
45%
- Selling and Administrative Expenses 2,936 2,936
25% 25%
15%
- Research and Development Expense 1,190 1,190
4% 4%
6%
5,027 5,027
10% 10%
25%
- Depreciation and Amortization 2,144 2,144
1% 1%
11%
EBIT (Operating Income) EBIT 2,883 2,883
19% 19%
14%
Net Profit 1,726 1,726
16% 16%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Becton, Dickinson & directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Becton, Dickinson & Stock News

Neutral
PRNewsWire
9 days ago
FRANKLIN LAKES, N.J. and AUSTIN, Texas , Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, today announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other large provider networks in settings ...
Negative
Reuters
10 days ago
The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. over allegations it misled investors about risks associated with its Alaris infusion pump.
Neutral
PRNewsWire
10 days ago
FRANKLIN LAKES, N.J. , Dec. 16, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement: BD has reached an agreement with the U.S. Securities and Exchange Commission (SEC) to resolve the previously disclosed investigation related to prior public disclosures and SEC reporting regarding the BD Alaris™ S...
More Becton, Dickinson & News

Company Profile

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.

Head office United States
CEO Thomas Polen
Employees 74,000
Founded 1897
Website www.bd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today